EOLS

Evolus, Inc. develops and commercializes aesthetic products, primarily focusing on the neurotoxin Jeuveau, which is used for the treatment of moderate to severe glabellar lines. The company utilizes a proprietary manufacturing process that ensures high product purity and efficacy. Evolus serves healthcare professionals and their patients, primarily in the aesthetic medicine market, and operates in the United States and select international markets.